NCT06502106

Brief Summary

The research aims to assess the practicality and implementation aspects, effectiveness, and processes of change related to Condensed Internet-delivered Prolonged Exposure (CIPE) administered as an early trauma focused intervention after sexual assault. Eligible participants are individuals seeking help at Traumamottagning Centrum för Sexuell Hälsa, Malmö who have been exposed to sexual assualt in the past two months and exhibit psychological symptoms in response to that.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 16, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

July 9, 2024

Last Update Submit

July 9, 2024

Conditions

Keywords

condensed prolonged exposurePTSDinternetdeliveredtraumaearly interventionpreventionCIPE

Outcome Measures

Primary Outcomes (1)

  • Change in PTSD symptoms as assessed by the PTSD Check List - DSM-5 (PCL-5)

    The PCL-5 is a 20-item self-report measure based upon the Diagnostic and Statistical Manual (DSM-5) criteria for PTSD. Total Score (Range 0-80 with higher scores representing more PTSD symptoms.

    Baseline, weekly through three weeks of treatment, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

Secondary Outcomes (7)

  • Change in depressive symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9)

    Baseline, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • Clinician Administered PTSD Scale version 5 (CAPS-5), the gold standard clinical interview to assess PTSD symptom severity and diagnosis of PTSD

    Three months after treatment completion.

  • The International Trauma Questionnaire (ITQ)

    Baseline, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • Change in psychosocial impairment measured by The Work and Social Adjustment Scale (WSAS), adapted to symptoms of post-traumatic stress.

    Baseline, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • Change in quality of life measured by EQ-5D

    Baseline, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • +2 more secondary outcomes

Other Outcomes (12)

  • Adverse events related to treatment measured by an openended question

    Baseline, weekly through three weeks of treatment, post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • Adverse events realted to treatment measured by Negative effects questionnaire (NEQ)

    Post-treatment (immediately after treatment completion at three weeks), and the 1 month, 3 month, 6 month and 12 month follow up.

  • Participants satisfaction with treatment

    Immediately after treatment completion.

  • +9 more other outcomes

Study Arms (1)

Condensed Internet delivered prolonged exposure (CIPE)

EXPERIMENTAL

Condensed Internet delivered prolonged exposure (CIPE) for three weeks with therapist support.

Behavioral: Condensed Internet delivered prolonged exposure (CIPE)

Interventions

Condensed Internet delivered prolonged exposure (CIPE) with therapist support for three weeks.

Condensed Internet delivered prolonged exposure (CIPE)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Experienced trauma in the past two months according to criterion A for PTSD in the DSM-5 (exposed to death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence).
  • At least mild clinical symptoms assessed using the PCL-5 cut-off \>10
  • ≥ 18 years
  • Signed informed consent

You may not qualify if:

  • Other serious comorbidity as primary concern (ongoing substance dependence, untreated bipolar disorder, psychotic symptoms, severe depression, borderline personality disorder, high suicidal risk)
  • Unable to read and write in Swedish
  • Receiving other psychological trauma-focused treatment
  • Ongoing trauma-related threat (e.g., living with a violent spouse)
  • Not stable dose of antidepressant medication the last two weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Traumamottagning Centrum för Sexuell Hälsa, Skånes Universitetssjukhus

Malmo, Sweden

Location

MeSH Terms

Conditions

Stress Disorders, Traumatic, AcuteStress Disorders, Post-TraumaticWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Maria Bragesjö, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maria Bragesjö, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prolonged exposure will be offered in a brief digital format with therapist support for three weeks. Treatment comprises of psychoeducation, rationales, in vivo exposure, imaginal exposure and relapse prevention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Princicpal investigator, PhD

Study Record Dates

First Submitted

July 9, 2024

First Posted

July 16, 2024

Study Start

October 1, 2024

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

July 16, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations